MedPath
HSA Approval

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml

SIN10539P

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml

December 11, 1998

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AD02

promethazine

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

PROMETHAZINE HCl

5 mg/5 ml

Promethazine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL PROMETHAZINE-5 SYRUP 5 mg/5 ml - HSA Approval | MedPath